Guinea pig Hageman factor as a vascular permeability enhancement factor.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  American Journal of Pathology

• Publication date

  1981-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 6794374PMCID PMC1903878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of bovine factor XII (Hageman factor) by plasma kallikrein.

  1980cited by this paper
• Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.

  1980cited by this paper
• Enzymatic properties of human Hageman factor fragment with plasma prekallikrein and synthetic substrates.

  1980cited by this paper
• A proteaselike permeability factor in guinea pig skin: contact activation of the latent permeability factor and its nature as a prekallikrein activator.

  1980cited by this paper
• A protease-like permeability factor in the guinea pig skin. 2. In vitro activation of the latent form permeability factor by weakly acidic phosphate buffer.

  1978cited by this paper
• A protease-like permeability factor in the guinea pig skin. 1. Partial purification and characterization.

  1978cited by this paper
• Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

  1978cited by this paper
• A protease-like permeability factor in the guinea pig skin : partial purification and characterization

  1977cited by this paper
• Characterization of bovine factor XIIa (activated Hageman factor).

  1977cited by this paper
• Isolation and characterization of bovine factor XII (Hageman factor).

  1977cited by this paper
• Human factor XII (Hageman factor).

  1976cited by this paper
• Radioimmunoassay of human Hageman factor (factor XII).

  1976cited by this paper
• The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

  1976cited by this paper
• Vascular permeability factors (PF/Nat and PF/Dil)--their relationship to Hageman factor and the kallikrein-kinin system.

  1975cited by this paper
• Flaujeac trait. Deficiency of human plasma kininogen.

  1975cited by this paper
• Structural changes accompanying enzymatic activation of human Hageman factor.

  1974cited by this paper
• The relationship between PF-DIL and activated human Hageman factor.

  1974cited by this paper
• The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.

  1974cited by this paper
• PREKALLIKREIN DEFICIENCY IN MAN

  1973cited by this paper
• Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates.

  1972cited by this paper
• Conversion of Hageman factor (Factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor

  1972cited by this paper
• Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: Possible relationship to Hageman factor

  1972cited by this paper
• THE FIRST COMPONENT OF THE KININ-FORMING SYSTEM IN HUMAN AND RABBIT PLASMA

  1971cited by this paper
• Simple Method for Quantitation of Enhanced Vascular Permeability 1

  1970cited by this paper
• A pre-albumin activator of prekallikrein.

  1970cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• [Activation of the coagulation and kinin system by a plasma esterase (Hageman factor): purification and conditions of activity].

  1969cited by this paper
• Abolition of the permeability-enhancing properties of Hageman factor by specific antiserum.

  1967cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• A study of capillary permeability and its possible relationship to clotting factor XII.

  1965cited by this paper
• DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *

  1964cited by this paper
• THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.

  1964cited by this paper
• THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM.

  1963cited by this paper
• Diffusion-in-gel methods for immunological analysis.

  1958cited by this paper
• Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. V. Activable permeability factor in human serum.

  1958cited by this paper
• Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. IV. Activable permeability factor and its inhibitor in the serum of the rat and the rabbit.

  1958cited by this paper
• Activation of a Permeability Factor in Plasma by Contact with Glass

  1958cited by this paper
• Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. III. Further observations on the permeability factor and its inhibitor in guinea-pig serum.

  1957cited by this paper
• The permeability-increasing factor in diluted human plasma.

  1957cited by this paper
• Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor.

  1955cited by this paper
• Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.

  1955cited by this paper
• Susceptibility of the Guinea Pig to Pharmacological Factors from its Own Serum

  1953cited by this paper

• Stimulation der Wundheilung durch wiederholte lokale Applikation von Insulin-like growth factor-I (IGF-I) unter dem Aspekt unterschiedlicher Applikationsformen

  2008cites this paper
• C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2

  2005cites this paper
• Monitoring of immunotherapy with cytokines or monoclonal antibodies

  2004cites this paper
• Cytokines, coagulation and fibrinolysis

  1999cites this paper
• The Role of the Contact System in the Pathogenesis of Septic Shock

  1999cites this paper
• Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein.

  1996cites this paper
• Species differences in amino acid sequences of Hageman factor and prekallikrein at region around scissile bond in activation.

  1996cites this paper
• Role of alpha-2-macroglobulin and bacterial elastase in guinea-pig pseudomonal septic shock.

  1995cites this paper
• T-cell chemotactic activity of cytokine LD78: a comparative study with interleukin-8, a chemotactic factor for the T-cell CD45RA+ phenotype.

  1993cites this paper
• Difference between human and guinea pig Hageman factors in activation by bacterial proteinases: cleavage site shift due to local amino acid substitutions may determine the activation efficiency of serine proteinase zymogens.

  1993cites this paper
• Role of Hageman factor/kallikrein-kinin system in pseudomonal elastase-induced shock model.

  1993cites this paper
• Exocellulr Toxic Factors Prowced by Vibrio Vulnificus

  1993cites this paper
• Activation of human plasma prekallikrein by Pseudomonas aeruginosa elastase. II. Kinetic analysis and identification of scissile bond of prekallikrein in the activation.

  1992cites this paper
• Primary structure of guinea-pig Hageman factor: sequence around the cleavage site differs from the human molecule.

  1992cites this paper
• Proteinases as Mediators of the Disturbance of Pulmonary Vascular Permeability in Sepsis, Polytrauma, and ARDS

  1992cites this paper
• Studies on the Contact System of Coagulation during Therapy with High Doses of Recombinant IL-2: Implications for Septic Shock

  1991cites this paper
• Actions and interactions of mediator systems and mediators in the pathogenesis of ARDS and multiorgan failure

  1991cites this paper
• Activation of human plasma prekallikrein by Pseudomonas aeruginosa elastase in vitro.

  1991cites this paper
• Role of Proteinases in the Pathophysiology of Organ Failure

  1990cites this paper
• Activation of human Hageman factor by Pseudomonas aeruginosa elastase in the presence or absence of negatively charged substance in vitro.

  1990cites this paper
• Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases.

  1989cites this paper
• Hageman factor dependent kinin generation system in guinea pig skin: extravascular localization of the components, and prolonged vascular reaction in inhibitor-depleted animal of this system.

  1989cites this paper
• Antigen presentation at the inflammatory site.

  1989cites this paper
• The major plasma kallikrein inhibitor in guinea pig plasma with contrapsin-like nature.

  1989cites this paper
• Purification of factor XII from porcine plasma and its activation by porcine plasma kallikrein.

  1989cites this paper
• [Role of the contact plasma system in human physiopathology].

  1989cites this paper
• The Hageman factor-dependent system in the vascular permeability reaction.

  1988cites this paper
• 3. Ursachen und Therapie von Organversagen: Mediatoren, ihr Stellenwert und therapeutische Implikationen am Beispiel des septischen Patienten

  1987cites this paper
• [Causes and therapy of organ failure: mediators, their role and therapeutic implications as exemplified by the infected patient].

  1987cites this paper
• Structural and Functional Characterization of Factor XII

  1987cites this paper
• Characterization of guinea-pig high-molecular-weight kininogen as multi-functional molecule.

  1987cites this paper
• Interstitial-tissue localization of high-molecular-weight kininogen in guinea-pig skin.

  1987cites this paper
• Immunohistochemical studies on synthesis and distribution of Hageman factor and kininogen.

  1986cites this paper
• Enhancement of vascular permeability upon serratial infection: activation of Hageman factor--kallikrein--kinin cascade.

  1986cites this paper
• Hageman factor dependent pathway in local vascular permeability enhancement.

  1986cites this paper
• Application of a new method of antibody-enzyme conjugation with maleimide derivative for immunohistochemistry: hepatocellular production, interstitial tissue distribution, and renal cell reabsorption of plasma albumin in guinea pig.

  1985cites this paper
• The glomerular polyanion (GPA) of the rat kidney. III. Further characterization of a vaso-active serum factor which reduces GPA.

  1985cites this paper
• The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study.

  1985cites this paper
• A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs

  1985cites this paper
• A high-molecular-weight trypsinlike protease in the skin sites of delayed hypersensitivity in guinea pigs.

  1984cites this paper
• Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

  1984cites this paper
• Chapter 4 – Platelet-activating factor

  1984cites this paper
• Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature.

  1984cites this paper
• The Contact (Hageman Factor) System in Inflammation

  1983cites this paper
• IMMUNOPATHOLOGICAL CHARACTERIZATION OF THE DELAYED HYPERSENSITIVITY SKIN REACTION TO CARRIER PROTEIN

  1983cites this paper
• The biochemistry and pathophysiology of the contact system of plasma.

  1982cites this paper
• Hageman factor deposition in membranous glomerulopathy.

  1982cites this paper
• A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor.

  1982cites this paper